Showing results (41-50 of 111) with videos related to
Sort By:
Pageof 12
JAMA Network Open|August 6, 2021
Association of Thrombosis With Hypereosinophilic Syndrome in Patients With Genetic AlterationsOrly Leiva, Olesya Baker, Andrew Jenkins, et al.Cancer|October 6, 2018
Low clinical trial accrual of patients with myelodysplastic syndromes: Causes and potential solutionsDavid P Steensma, Andrew M Brunner, Amy E DeZern, et al.Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 21, 2017
Acute Leukemia is Associated with Cardiac Alterations before ChemotherapyBruna Morhy Borges Leal Assuncao, Mark D Handschumacher, Andrew M Brunner, et al.Clinical Lymphoma, Myeloma & Leukemia|April 5, 2025
Advancing the Management of CH, MDS, and AML From the First Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma ConferenceHetty E Carraway, Andrew M Brunner, Catherine E Lai, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2014
Phase I study of urate oxidase in the reduction of acute graft-versus-host disease after myeloablative allogeneic stem cell transplantationAlbert C Yeh, Andrew M Brunner, Thomas R Spitzer, et al.American Journal of Hematology|April 27, 2013
Association between baseline body mass index and overall survival among patients over age 60 with acute myeloid leukemiaAndrew M Brunner, Hossein Sadrzadeh, Yang Feng, et al.Journal of the National Cancer Institute|March 22, 2024
Racial and ethnic associations with comprehensive cancer center access and clinical trial enrollment for acute leukemiaAndrew Hantel, Andrew M Brunner, Jesse J Plascak, et al.Leukemia|January 4, 2024
Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium ProtocolsYannis K Valtis, Yael Flamand, Shai Shimony, et al.Haematologica|February 10, 2022
Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and <i>BCR-ABL</i>-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicinSabine Kayser, Chiara Sartor, Marlise R Luskin, et al.Blood Advances|July 11, 2023
Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trialsShai Shimony, Yael Flamand, Yannis K Valtis, et al.Pageof 12